Andy Goren

InstitutionApplied Biology
AddressIrvine
California
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 30 Covid-19 publications, with a maximum of 5 publications in July 2020
    All Publications
    Bar chart showing 56 publications over 12 distinct years, with a maximum of 20 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abrantes TF, Artounian KA, Falsey R, Simão JCL, Vañó-Galván S, Ferreira SB, Davis TL, Ridenour W, Goren A, Tosti A, Wambier CG. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021 10; 85(4):975-976. PMID: 34302903.
      Citations: 1     Fields:    Translation:Humans
    2. McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Front Med (Lausanne). 2021; 8:668698. PMID: 34350193.
      Citations: 6     
    3. Arora P, Mrig S, Goldust Y, Kroumpouzos G, Karadag AS, Rudnicka L, Galadari H, Szepietowski JC, Di Lernia V, Goren A, Kassir M, Goldust M. New Coronavirus (SARS-CoV-2) Crossing Borders Beyond Cities, Nations, and Continents: Impact of International Travel. Balkan Med J. 2021 07; 38(4):205-211. PMID: 34274909.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Nguyen C, Yale K, Ghigi A, Zheng K, Mesinkovska NA, Wambier CG, Cadegiani FA, Goren A. SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Ann Thyroid. 2022 Mar; 6. PMID: 34151187.
      Citations:    
    5. Zimerman RA, Cadegiani FA, Pereira E Costa RA, Goren A, Campello de Souza B. Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants. Cureus. 2021 Mar 11; 13(3):e13819. PMID: 33728228.
      Citations: 2     
    6. Yale K, Elsanadi R, Ghigi A, Zheng K, Goren A, Mesinkovska NA. Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism. Int J Dermatol. 2021 Jul; 60(7):e267-e268. PMID: 33650165.
      Citations: 1     Fields:    Translation:Humans
    7. Cadegiani F, Lin EM, Goren A, Wambier CG. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26; 14(2). PMID: 33637513.
      Citations: 6     Fields:    Translation:Humans
    8. Cadegiani FA, McCoy J, Gustavo Wambier C, Vaño-Galván S, Shapiro J, Tosti A, Zimerman RA, Goren A. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial. Cureus. 2021 Feb 22; 13(2):e13492. PMID: 33633920.
      Citations: 15     
    9. Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical). Cureus. 2021 Feb 01; 13(2):e13047. PMID: 33643746.
      Citations: 14     
    10. Cadegiani FA, Zimerman RA, Campello de Souza B, McCoy J, Pereira E Costa RA, Gustavo Wambier C, Goren A. The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort. Cureus. 2021 Jan 07; 13(1):e12565. PMID: 33437562.
      Citations: 5     
    11. Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J. Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster. Med Hypotheses. 2021 01; 146:110439. PMID: 33308937.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    12. Wambier CG, Vaño-Galván S, Goren A. Reply to comment on: The Gabrin sign. J Am Acad Dermatol. 2021 03; 84(3):e149-e150. PMID: 33253847.
      Citations:    Fields:    
    13. McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. J Eur Acad Dermatol Venereol. 2021 Apr; 35(4):e243-e246. PMID: 33135263.
      Citations: 18     Fields:    Translation:Humans
    14. Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG. Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):e101-e104. PMID: 33089570.
      Citations: 10     Fields:    Translation:Humans
    15. McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e15-e17. PMID: 32977355.
      Citations: 10     Fields:    Translation:Humans
    16. Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e13-e15. PMID: 32977363.
      Citations: 19     Fields:    Translation:Humans
    17. Lin EM, Goren A, Wambier C. Letter to the Editor: Environmental Effects on Reported Infections and Death Rates of COVID-19 Across 91 Major Brazilian Cities. High Alt Med Biol. 2020 12; 21(4):431-433. PMID: 33031012.
      Citations: 3     Fields:    Translation:Humans
    18. Wambier CG, McCoy J, Goren A. Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals. J Am Acad Dermatol. 2020 12; 83(6):e401-e402. PMID: 32926978.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    19. Ianhez M, Ramos PM, Goren A, Miot HA. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Dermatol Ther. 2020 11; 33(6):e14166. PMID: 32772478.
      Citations:    Fields:    Translation:Humans
    20. Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A. Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign. J Am Acad Dermatol. 2020 12; 83(6):e453-e454. PMID: 32735970.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    21. Lim RK, Wambier CG, Goren A. Are night shift workers at an increased risk for COVID-19? Med Hypotheses. 2020 Nov; 144:110147. PMID: 32758906.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    22. Cadegiani FA, Wambier CG, Goren A. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Front Med (Lausanne). 2020; 7:453. PMID: 32850920.
      Citations: 12     
    23. Cadegiani FA, Goren A, Wambier CG. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Med Hypotheses. 2020 Oct; 143:110112. PMID: 32721806.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    24. Goren A, Rathod D, Kroumpouzos G, Jafferany M, Goldust M. Safety measures in dermatology help minimize spread of COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13773. PMID: 32506600.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    25. McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Ramos PM, Washenik K, Andrade M, Herrera S, Goren A. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020 Jul; 19(7):1542-1543. PMID: 32333494.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    26. Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol. 2020 Aug; 83(2):680-682. PMID: 32446821.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    27. Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020 11; 81(7):771-776. PMID: 32412125.
      Citations: 47     Fields:    Translation:HumansPHPublic Health
    28. Goren A, Vaño-Galván S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washenik K. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020 Jul; 19(7):1545-1547. PMID: 32301221.
      Citations: 56     Fields:    Translation:HumansPHPublic Health
    29. Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020 Jul; 83(1):308-309. PMID: 32283245.
      Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
    30. Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020 Jul; 33(4):e13365. PMID: 32237190.
      Citations: 17     Fields:    Translation:HumansAnimalsPHPublic Health
    Goren's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (170)
    Explore
    _
    Co-Authors (97)
    Explore
    _
    Similar People (60)
    Explore
    _